Results 81 to 90 of about 171,941 (345)

Real-World Achievement of Guideline-Concordant Treatment and Survival in Osteosarcoma: A Nationwide Registry Study. [PDF]

open access: yesCancer Sci
A nationwide registry analysis showed that real‐world achievement of guideline‐concordant treatment was high across Japan and associated with superior survival in osteosarcoma patients. Older age and trunk tumor location were associated with lower rates of achievement of guideline‐concordant treatment, largely reflecting treatment feasibility.
Fujiwara T, Kawai A, Ozaki T.
europepmc   +2 more sources

Loss of E3 Ubiquitin Ligase RINES via CpG Methylation Relieves Suppression of STAT3 and MYC, Facilitating Multiple Tumorigeneses

open access: yesAdvanced Science, EarlyView.
Dysregulated protein modifications drive tumorigenesis. RINES, an E3 ubiquitin ligase, represses tumor cell proliferation and metastasis by facilitating RING domain‐dependent, ubiquitin–proteasome‐mediated degradation of STAT3 and MYC, which consequently restrains cancer stemness and oncogenic progression.
Lili Li   +8 more
wiley   +1 more source

SERPINH1 enhances the malignancy of osteosarcoma via PI3K-Akt signaling pathway

open access: yesTranslational Oncology
Background: Serpin Family H Member 1 (SERPINH1) may be involved in the regulation of occurrence and development of tumors. However, the role and mechanism of SERPINH1 in osteosarcoma remain poorly understood.
Kezhou Xia   +4 more
doaj   +1 more source

Telangiectatic Osteosarcoma: Ultrastrucural and Immunohistochemical observations

open access: yes, 1996
Telangiectatic Osteosarcoma: Ultrastrucural and Immunohistochemical ...
COMIN C. E.   +5 more
core  

Osteosarcoma

open access: yes, 2021
Osteosarcoma is the most common type of cancer that starts in bones. I will be researching and presenting on the visual differences between healthy bone tissue and bone tissue that has been affected by osteosarcoma as well as symptoms and preventative ...
Retz, Andrew
core  

A Rare De Novo Missense Mutation in IFT122 Confers a Genetic Susceptibility Factor of Idiopathic Pediatric Uveitis Via Trio‐based Whole‐Exome Sequencing

open access: yesAdvanced Science, EarlyView.
A rare de novo IFT122‐A773E variant is identified in idiopathic pediatric uveitis and shown to exacerbate retinal inflammation and barrier dysfunction. Mechanistically, the variant enhances IFT43 interaction, elevates calcium signaling, and activates the MEK/ERK/FRA1 axis, revealing a previously unrecognized cilia‐associated pathway that may increase ...
Qian Zhou   +18 more
wiley   +1 more source

ONZIN Upregulation by Mutant p53 Contributes to Osteosarcoma Metastasis Through the CXCL5-MAPK Signaling Pathway

open access: yesCellular Physiology and Biochemistry, 2018
Background/Aims: Gain-of-function of mutant p53 is associated with a high rate of lung metastasis in osteosarcoma. To investigate the mechanism of mutant p53-induced osteosarcoma metastasis, expression array analysis was performed, comparing non ...
Yanqin Zhang   +15 more
doaj   +1 more source

Osteosarcoma costal [PDF]

open access: yes, 1944
I El Prof. Luque presenta la historia clínica, con dos ilustraciones, de un joven con un tumor localizado en la región intervértebro-escapular derecha.
Luque, Manuel José, Manuel José Luque
core  

Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/STAT3 Pathway

open access: yes, 2023
Wen Ting Zhu,1,* Xiang Feng Zeng,2,* Hua Yang,2 Meng Lei Jia,1 Wei Zhang,2 Wei Liu,2 Sheng Yao Liu3 1Department of Pharmacy, Biomedicine Research Center, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, The Third Affiliated ...
Yang H   +6 more
core  

Circulating exosomes secreted by osteosarcoma cells are potential biomarkers for metastasis

open access: yes, 2021
Selva, Erica M.Sampson, ValerieOsteosarcoma is a primary malignant bone tumor found in children and is the third most common cancer in children and adolescents.
Jeshurin, Madeline
core   +1 more source

Home - About - Disclaimer - Privacy